Clinical Rheumatology

, Volume 33, Issue 7, pp 885–891 | Cite as

Fibromyalgia and chronic widespread pain in autoimmune thyroid disease

  • Jowairiyya Ahmad
  • Clement E. TagoeEmail author
Review Article


Fibromyalgia and chronic widespread pain syndromes are among the commonest diseases seen in rheumatology practice. Despite advances in the management of these conditions, they remain significant causes of morbidity and disability. Autoimmune thyroid disease is the most prevalent autoimmune disorder, affecting about 10 % of the population, and is a recognized cause of fibromyalgia and chronic widespread pain. Recent reports are shedding light on the mechanisms of pain generation in autoimmune thyroid disease-associated pain syndromes including the role of inflammatory mediators, small-fiber polyneuropathy, and central sensitization. The gradual elucidation of these pain pathways is allowing the rational use of pharmacotherapy in the management of chronic widespread pain in autoimmune thyroid disease. This review looks at the current understanding of the prevalence of pain syndromes in autoimmune thyroid disease, their likely causes, present appreciation of the pathogenesis of chronic widespread pain, and how our knowledge can be used to find lasting and effective treatments for the pain syndromes associated with autoimmune thyroid disease.


Autoimmune thyroid disease Chronic lymphocytic thyroiditis Chronic widespread pain Fibromyalgia Hashimoto thyroiditis 





  1. 1.
    Vanhoof J, Declerck K, Geusens P (2002) Prevalence of rheumatic diseases in a rheumatological outpatient practice. Ann Rheum Dis 61:453–455PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Branco JC, Bannwarth B, Failde I et al (2010) Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 39:448–453PubMedCrossRefGoogle Scholar
  3. 3.
    Schaefer C, Chandran A, Hufstader M et al (2011) The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States. Health Qual Life Outcomes 9:71PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Spaeth M (2009) Epidemiology, costs, and the economic burden of fibromyalgia. Arthritis Res Ther 11:117PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Howard KJ, Mayer TG, Neblett R, Perez Y, Cohen H, Gatchel RJ (2010) Fibromyalgia syndrome in chronic disabling occupational musculoskeletal disorders: prevalence, risk factors, and posttreatment outcomes. J Occup Environ Med 52:1186–1191PubMedCrossRefGoogle Scholar
  6. 6.
    Stathatos N, Daniels GH (2012) Autoimmune thyroid disease. Curr Opin Rheumatol 24:70–75PubMedCrossRefGoogle Scholar
  7. 7.
    Weetman AP (2003) Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 148:1–9PubMedCrossRefGoogle Scholar
  8. 8.
    Czarnocka B (2011) Thyroperoxidase, thyroglobulin, Na(+)/I(−) symporter, pendrin in thyroid autoimmunity. Front Biosci (Landmark Ed) 16:783–802CrossRefGoogle Scholar
  9. 9.
    Pearce EN, Farwell AP, Braverman LE (2003) Thyroiditis. N Engl J Med 348:2646–2655PubMedCrossRefGoogle Scholar
  10. 10.
    Carette S, Lefrancois L (1988) Fibrositis and primary hypothyroidism. J Rheumatol 15:1418–1421PubMedGoogle Scholar
  11. 11.
    Kato K, Sullivan PF, Evengard B, Pedersen NL (2006) Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med 166:1649–1654PubMedCrossRefGoogle Scholar
  12. 12.
    Becker KL, Ferguson RH, Mc CW (1963) The connective-tissue diseases and symptoms associated with Hashimoto’s thyroiditis. N Engl J Med 268:277–280PubMedCrossRefGoogle Scholar
  13. 13.
    Golding DN (1970) Hypothyroidism presenting with musculoskeletal symptoms. Ann Rheum Dis 29:10–14PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Wilke WS, Sheeler LR, Makarowski WS (1981) Hypothyroidism with presenting symptoms of fibrositis. J Rheumatol 8:626–631PubMedGoogle Scholar
  15. 15.
    Bland JH, Frymoyer JW, Newberg AH, Revers R, Norman RJ (1979) Rheumatic syndromes in endocrine disease. Semin Arthritis Rheum 9:23–65PubMedCrossRefGoogle Scholar
  16. 16.
    Gillan MM, Scofield RH, Harley JB (2002) Hashimoto’s thyroiditis presenting as bilateral knee arthropathy. J Okla State Med Assoc 95:323–325PubMedGoogle Scholar
  17. 17.
    Kloppenburg M, Dijkmans BA, Rasker JJ (1993) Effect of therapy for thyroid dysfunction on musculoskeletal symptoms. Clin Rheumatol 12:341–345PubMedCrossRefGoogle Scholar
  18. 18.
    Golding DN (1993) Rheumatism and the thyroid. J R Soc Med 86:130–132PubMedCentralPubMedGoogle Scholar
  19. 19.
    Aarflot T, Bruusgaard D (1996) Association between chronic widespread musculoskeletal complaints and thyroid autoimmunity. Results from a community survey. Scand J Prim Health Care 14:111–115PubMedCrossRefGoogle Scholar
  20. 20.
    Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–172PubMedCrossRefGoogle Scholar
  21. 21.
    Bazzichi L, Rossi A, Giuliano T et al (2007) Association between thyroid autoimmunity and fibromyalgic disease severity. Clin Rheumatol 26:2115–2120PubMedCrossRefGoogle Scholar
  22. 22.
    Bazzichi L, Rossi A, Zirafa C et al (2012) Thyroid autoimmunity may represent a predisposition for the development of fibromyalgia? Rheumatol Int 32:335–341PubMedCrossRefGoogle Scholar
  23. 23.
    Pamuk ON, Cakir N (2007) The frequency of thyroid antibodies in fibromyalgia patients and their relationship with symptoms. Clin Rheumatol 26:55–59PubMedCrossRefGoogle Scholar
  24. 24.
    Suk JH, Lee JH, Kim JM (2012) Association between thyroid autoimmunity and fibromyalgia. Exp Clin Endocrinol Diabetes 120:401–404PubMedCrossRefGoogle Scholar
  25. 25.
    Ribeiro LS, Proietti FA (2004) Interrelations between fibromyalgia, thyroid autoantibodies, and depression. J Rheumatol 31:2036–2040PubMedGoogle Scholar
  26. 26.
    Wolfe F, Brahler E, Hinz A, Hauser W (2013) Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res (Hoboken) 65:777–785CrossRefGoogle Scholar
  27. 27.
    Soy M, Guldiken S, Arikan E, Altun BU, Tugrul A (2007) Frequency of rheumatic diseases in patients with autoimmune thyroid disease. Rheumatol Int 27:575–577PubMedCrossRefGoogle Scholar
  28. 28.
    Tagoe CE, Zezon A, Khattri S, Castellanos P (2013) Rheumatic manifestations of euthyroid, anti-thyroid antibody-positive patients. Rheumatol Int 33:1745–1752PubMedCrossRefGoogle Scholar
  29. 29.
    Biro E, Szekanecz Z, Czirjak L et al (2006) Association of systemic and thyroid autoimmune diseases. Clin Rheumatol 25:240–245PubMedCrossRefGoogle Scholar
  30. 30.
    Boelaert K, Newby PR, Simmonds MJ et al (2010) Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med 123:183, e1-9PubMedCrossRefGoogle Scholar
  31. 31.
    Cho JH, Gregersen PK (2011) Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 365:1612–1623PubMedCrossRefGoogle Scholar
  32. 32.
    Lazurova I, Benhatchi K, Rovensky J et al (2009) Autoimmune thyroid disease and autoimmune rheumatic disorders: a two-sided analysis. Ann N Y Acad Sci 1173:211–216PubMedCrossRefGoogle Scholar
  33. 33.
    Buskila D, Sarzi-Puttini P (2008) Fibromyalgia and autoimmune diseases: the pain behind autoimmunity. Isr Med Assoc J 10:77–78PubMedGoogle Scholar
  34. 34.
    Koroschetz J, Rehm SE, Gockel U et al (2011) Fibromyalgia and neuropathic pain—differences and similarities. A comparison of 3,057 patients with diabetic painful neuropathy and fibromyalgia. BMC Neurol 11:55PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    Oaklander AL, Herzog ZD, Downs HM, Klein MM (2013) Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. PainGoogle Scholar
  36. 36.
    Orstavik K, Norheim I, Jorum E (2006) Pain and small-fiber neuropathy in patients with hypothyroidism. Neurology 67:786–791PubMedCrossRefGoogle Scholar
  37. 37.
    Molina F, Bouanani M, Pau B, Granier C (1996) Characterization of the type-1 repeat from thyroglobulin, a cysteine-rich module found in proteins from different families. Eur J Biochem 240:125–133PubMedCrossRefGoogle Scholar
  38. 38.
    Malthiery Y, Marriq C, Berge-Lefranc JL et al (1989) Thyroglobulin structure and function: recent advances. Biochimie 71:195–209PubMedCrossRefGoogle Scholar
  39. 39.
    Mori N, Itoh N, Salvaterra PM (1987) Evolutionary origin of cholinergic macromolecules and thyroglobulin. Proc Natl Acad Sci U S A 84:2813–2817PubMedCentralPubMedCrossRefGoogle Scholar
  40. 40.
    Weetman AP, Tse CK, Randall WR, Tsim KW, Barnard EA (1988) Acetylcholinesterase antibodies and thyroid autoimmunity. Clin Exp Immunol 71:96–99PubMedCentralPubMedGoogle Scholar
  41. 41.
    Desmeules JA, Cedraschi C, Rapiti E et al (2003) Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 48:1420–1429PubMedCrossRefGoogle Scholar
  42. 42.
    Watkins LR, Milligan ED, Maier SF (2001) Glial activation: a driving force for pathological pain. Trends Neurosci 24:450–455PubMedCrossRefGoogle Scholar
  43. 43.
    Watkins LR, Maier SF (2005) Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med 257:139–155PubMedCrossRefGoogle Scholar
  44. 44.
    Bellato E, Marini E, Castoldi F et al (2012) Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat 2012:426130PubMedCentralPubMedGoogle Scholar
  45. 45.
    Mohacsik P, Zeold A, Bianco AC, Gereben B (2011) Thyroid hormone and the neuroglia: both source and target. J Thyroid Res 2011:215718PubMedCentralPubMedCrossRefGoogle Scholar
  46. 46.
    Martinez-Lavin M (2013) Small fibre neuropathy, fibromyalgia and dorsal root ganglia sodium channels. Brain 136:e246PubMedCrossRefGoogle Scholar
  47. 47.
    Kawakami M, Tamaki T, Matsumoto T, Kuribayashi K, Takenaka T, Shinozaki M (2000) Role of leukocytes in radicular pain secondary to herniated nucleus pulposus. Clin Orthop Relat Res 268–277Google Scholar
  48. 48.
    Podolecki T, Podolecki A, Hrycek A (2009) Fibromyalgia: pathogenetic, diagnostic and therapeutic concerns. Pol Arch Med Wewn 119:157–161PubMedGoogle Scholar
  49. 49.
    Kidd BL, Urban LA (2001) Mechanisms of inflammatory pain. Br J Anaesth 87:3–11PubMedCrossRefGoogle Scholar
  50. 50.
    Tagoe CE, Zezon A, Khattri S (2012) Rheumatic manifestations of autoimmune thyroid disease: the other autoimmune disease. J Rheumatol 39:1125–1129PubMedCrossRefGoogle Scholar
  51. 51.
    Lee YC (2013) Effect and treatment of chronic pain in inflammatory arthritis. Curr Rheumatol Rep 15:300PubMedCentralPubMedCrossRefGoogle Scholar
  52. 52.
    Xiao Y, Haynes WL, Michalek JE, Russell IJ (2013) Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate. Rheumatol Int 33:1259–1264PubMedCrossRefGoogle Scholar
  53. 53.
    Kaklamanos M, Thomas D, Pikazis D, Christaki S, Kaltsas G (2013) The effect of rituximab on thyroid function and autoimmunity. Thyroid 23:1044–1045PubMedCrossRefGoogle Scholar
  54. 54.
    Raterman HG, Jamnitski A, Lems WF et al (2011) Improvement of thyroid function in hypothyroid patients with rheumatoid arthritis after 6 months of adalimumab treatment: a pilot study. J Rheumatol 38:247–251PubMedCrossRefGoogle Scholar
  55. 55.
    Atzeni F, Doria A, Ghirardello A et al (2008) Organ-specific autoantibodies in patients with rheumatoid arthritis treated with adalimumab: a prospective long-term follow-up. Autoimmunity 41:87–91PubMedCrossRefGoogle Scholar

Copyright information

© Clinical Rheumatology 2014

Authors and Affiliations

  1. 1.Department of GeriatricsAlbert Einstein College of MedicineBronxUSA
  2. 2.Department of MedicineAlbert Einstein College of MedicineBronxUSA
  3. 3.Division of RheumatologyMontefiore Medical CenterBronxUSA

Personalised recommendations